StemSynergy (SSTI) is a biotechnology company focused on the discovery and development of novel therapeutics that target mechanisms fundamental to cancer, such as Wnt, Notch, and Myc signaling.

Corporate HQ 1951 NW 7th Avenue Suite 300 Miami, FL, 33136 Get in Touch Phone: (305) 600-1048 Email: [email protected] Copyright Info © StemSynergy Therapeutics, Inc. All Rights Reserved.

Science SSTI is focused on the discovery and development of novel drugs that target molecules and cellular processes fundamental to cancer. Our drug targets include those in the Wnt, Notch, and Myc …

Contact Corporate Headquarters and R&D StemSynergy Therapeutics, Inc. 1951 NW 7th Avenue, Suite 300 Miami, FL 33136 Phone: (305) 600-1048 Email: [email protected]

StemSynergy Therapeutics Invited to Present at the NIH SBIR/STTR Innovation Zone at the BIO International Biotechnology Conferences (2014, 2020, 2024) Stemsynergy Therapeutics Announces …

StemSynergy Therapeutics is a pharmaceutical company focused on the discovery and development of novel small-molecule drugs that target signaling pathways fundamental to cancer.

Corporate HQ 1951 NW 7th Avenue Suite 300 Miami, FL, 33136 Get in Touch Phone: (305) 600-1048 Email: [email protected] Copyright Info © StemSynergy Therapeutics, Inc. All Rights Reserved.

Scientific Team The SSTI team has extensive working experience in the biotech/pharmaceutical industry. Our team has broad experience in medicinal chemistry, drug development and cancer …

As a group, the founders have many decades of experience in cancer research, raised tens of millions of dollars in grant support, and have eight patents filed or pending covering both lead-compounds and …

Dennis Fei, Ph.D. Dr. Dennis Fei is Director of Drug Discovery and Development at SSTI. Dr. Fei received his Ph.D. degree in Pharmacology and Toxicology at Dartmouth College. He completed his …